Comparison of Inhospital and 12- and 36-Month Outcomes After Acute Coronary Syndrome in Men Versus Women <40 Years (from the PL-ACS Registry)

Clinical characteristics, and in-hospital and long-term outcomes of stable angina treatment in patients below and over 40 years of age (from the PRESAGE registry)

“…Our in-hospital outcomes are in concordance with other studies reporting low mortality and complication rate among young patients with ACS [4,7,8] or undergoing PCI [9,10]. We did not note any significant difference in the in-hospital outcomes or in the incidence of composite endpoint between both groups during the follow-up period.…”

“…By and large, the first manifestation of coronary artery disease (CAD) at a younger age is acute coronary syndrome (ACS) or sudden cardiac death (SCD) [1]. Patients under 40 years of age represent 2% to 10% of all patients with ACS [2][3][4][5][6][7][8]. The incidence of SA among young patients is an issue often neglected both in the registries and in the available literature [5,[9][10][11].…”

Treatment and outcomes of patients under 40 years of age with acute myocardial infarction in Poland in 2009-2013 (analysis from PL-ACS Registry)

“…Similarly to other studies, our multivariate analysis indicated that Killip class 3 or 4 on admission and every 5% reduction of left ventricular ejection fraction were the strongest independent risk factors increasing the 12 -month incidence of the composite endpoint. 8,30 In conclusion, our study showed that there was no significant difference in the incidence of risk factors, comorbidities, and in -hospital and 12 -month outcomes between patients younger than 40 years with STEMI and NSTEMI hospitalized in the years 2009-2010 compared with those treated in the years 2012-2013. The percentage of patients with NSTEMI and that of performed coronary angiographies significantly increased over the years.…”

Adherence to guidelines for pharmacological treatment of young adults with myocardial infarction in Poland: Data from Polish Registry of Acute Coronary Syndromes (PL‐ACS)

“…[12][13][14] Moreover, some studies show that there is a gap between clinical guidelines and clinical practice regarding pharmacotherapy. [12][13][14] Moreover, some studies show that there is a gap between clinical guidelines and clinical practice regarding pharmacotherapy.…”

“…11 Previously conducted trials concerning young patients were focused on the whole Poland, neglecting possible differences in treatment among the provinces. [12][13][14] Moreover, some studies show that there is a gap between clinical guidelines and clinical practice regarding pharmacotherapy. 15 Therefore, there is a probability that a substantial proportion of MI patients do not receive medications according to the guidelines.…”